FTSE MIB
34.423,34 -180,27 (-0,52%) Dow Jones
39.872,99 +66,22 (+0,17%) Nasdaq
16.832,62 +37,75 (+0,22%) Nikkei 225
38.617,10 -329,83 (-0,85%) Petrolio
77,84 -0,82 (-1,04%) Bitcoin EUR
64.409,63 -1.056,50 (-1,61%)
Oxford Biomedica plc (OXB.L)
| Chiusura precedente | 331,50 |
| Aperto | 328,00 |
| Denaro | 329,00 x 0 |
| Domanda | 331,00 x 0 |
| Min-Max giorno | 326,10 - 336,30 |
| Intervallo di 52 settimane | 164,29 - 474,50 |
| Volume | |
| Media Volume | 373.555 |
| Capitalizzazione | 330,56M |
| Beta (mensile su 5 anni) | 0,94 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,63 |
| Prossima data utili | 29 apr 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 414,67 |
GlobeNewswireOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformation
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect
- GlobeNewswire
Oxford Biomedica to host webinar showcasing the TetraVecta™ system
Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral vector CDMO, today announces that it will host a webinar on the TetraVectaTM system, the Company’s 4th generation lentiviral vector delivery system, on Monday 2 October 2023. The webinar titled “4th Generation Lentiviral Vectors: An Improved Gene Delivery System” will feature presentations by D
